Psyence Biomedical Ltd. logo

PBMPsyence Biomedical Ltd.

PBM Stock Price, Valuation & Chart | Psyence Biomedical Ltd.

Compare

PBM Historical price chart

PBM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization83.11K
PE Ratio-0.01
EPS-393.1
Trading Volume21.35K
Today's High/Low4.46/4.35
Dividend Yield0.00
52 Week High/Low216.41/1.92
Shares Outstanding19.02K
PBM Financial Statement
PBM Analyst ratings
PBM Analysis & performance metrics

PBM Company profile

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment…

PBM Management team

Management
Neil Maresky M.D.CEO
Chief Executive Officer & Director
Jody Aufrichtig
Co-Founder, Executive Chairman & Strategic Business Development Officer
Warwick Ron Corden-LloydCFO
Chief Financial Officer
Taryn Vos
General Counsel
Total 4 executives

PBM Frequently asked questions

What is Psyence Biomedical Ltd. (PBM) Stock Price?

Current stock price of Psyence Biomedical Ltd. (PBM) stock is $4.370. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Psyence Biomedical Ltd. (PBM) stock is 21.35K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Psyence Biomedical Ltd. (PBM) stock price going up or down today?

The stock price of Psyence Biomedical Ltd. (PBM) can change with earnings, company news, and overall market sentiment. Psyence Biomedical Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Psyence Biomedical Ltd. stock expensive at its current price?

Whether Psyence Biomedical Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PBM on this page is -0.01. EPS on this page is -393.10. Compare those figures with peers and growth expectations before deciding if the current Psyence Biomedical Ltd. price is justified.

How has the stock price of Psyence Biomedical Ltd. (PBM) performed historically?

Historical performance for Psyence Biomedical Ltd. (PBM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PBM reacted to past earnings and market events.

Should I buy Psyence Biomedical Ltd. (PBM) stock, at this price?

Buying Psyence Biomedical Ltd. (PBM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.